Validation of senescence as a therapeutic target in metabolic dysfunction–associated steatohepatitis (MASH) through navitoclax delivery
- DOI
- 10.1016/j.jconrel.2026.115504
- Published
- 2026-11
- Container
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2026.115504,
title = {Validation of senescence as a therapeutic target in metabolic dysfunction–associated steatohepatitis (MASH) through navitoclax delivery},
author = {Yidi Jiang and Shuangmei Li and Elisa A. Liehn and Chee Seng Chan and Ji Xin Tan and Tian Xin Phua and Shing Leng Chan and Choon Keong Lee and Xiangliang Lin and Natalie Jun Hui Soh and Gabriele Grassi and Jiong-Wei Wang and Tong Wang and Brijesh Kumar Singh and Madhulika Tripathi and Wei Seong Toh and Victor C. Yu and Giorgia Pastorin},
year = {2026},
journal = {Journal of Controlled Release},
doi = {10.1016/j.jconrel.2026.115504},
url = {https://doi.org/10.1016/j.jconrel.2026.115504}
}RIS
TY - JOUR TI - Validation of senescence as a therapeutic target in metabolic dysfunction–associated steatohepatitis (MASH) through navitoclax delivery AU - Yidi Jiang AU - Shuangmei Li AU - Elisa A. Liehn AU - Chee Seng Chan AU - Ji Xin Tan AU - Tian Xin Phua AU - Shing Leng Chan AU - Choon Keong Lee AU - Xiangliang Lin AU - Natalie Jun Hui Soh AU - Gabriele Grassi AU - Jiong-Wei Wang AU - Tong Wang AU - Brijesh Kumar Singh AU - Madhulika Tripathi AU - Wei Seong Toh AU - Victor C. Yu AU - Giorgia Pastorin PY - 2026 JO - Journal of Controlled Release DO - 10.1016/j.jconrel.2026.115504 UR - https://doi.org/10.1016/j.jconrel.2026.115504 ER -
APA
Jiang, Y., Li, S., Liehn, E. A., Chan, C. S., Tan, J. X., Phua, T. X., Chan, S. L., Lee, C. K., Lin, X., Soh, N. J. H., Grassi, G., Wang, J., Wang, T., Singh, B. K., Tripathi, M., Toh, W. S., Yu, V. C., & Pastorin, G. (2026). Validation of senescence as a therapeutic target in metabolic dysfunction–associated steatohepatitis (MASH) through navitoclax delivery. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2026.115504
Source records
- crossref · retrieved 2026-11-04T13:13:02.184Z